SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: fred hayes who wrote (6263)1/18/2005 2:15:39 AM
From: Robohogs  Read Replies (1) | Respond to of 10345
 
And B?

Jon



To: fred hayes who wrote (6263)1/18/2005 2:58:57 AM
From: mopgcw  Read Replies (1) | Respond to of 10345
 
I agree somewhat with you Fred, but I do not believe T will take the spotlight, #1 so quickly, despite the hype. I think it will be a slow ramp, the quick pick-up will be those not responding to Avonex and those going on combo therapy. I agree Copaxone is toast.



To: fred hayes who wrote (6263)1/18/2005 8:00:31 AM
From: rkrw  Respond to of 10345
 
Rebif will be #1 because Serono and Robgera said so :-)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News